Annual Operating Expenses
$63.96 M
+$13.73 M+27.33%
December 31, 2022
Summary
- As of February 10, 2025, DBTX annual total operating expenses is $63.96 million, with the most recent change of +$13.73 million (+27.33%) on December 31, 2022.
- During the last 3 years, DBTX annual operating expenses has risen by +$19.88 million (+45.09%).
Performance
DBTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$19.04 M
+$4.92 M+34.84%
June 30, 2023
Summary
- As of February 10, 2025, DBTX quarterly total operating expenses is $19.04 million, with the most recent change of +$4.92 million (+34.84%) on June 30, 2023.
- Over the past year, DBTX quarterly operating expenses has increased by +$1.94 million (+11.33%).
Performance
DBTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
DBTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.3% | +11.3% |
| 3 y3 years | +45.1% | +142.4% |
| 5 y5 years | +68.9% | - |
DBTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -21.5% | at high | -32.2% |
| 5 y | 5-year | at high | -38.1% | at high | -66.2% |
| alltime | all time | at high | -40.8% | at high | -66.2% |
Decibel Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $19.04 M(+34.8%) |
| Mar 2023 | - | $14.12 M(-14.3%) |
| Dec 2022 | $63.96 M(+27.3%) | $16.49 M(+0.8%) |
| Sep 2022 | - | $16.35 M(-4.4%) |
| Jun 2022 | - | $17.10 M(+22.0%) |
| Mar 2022 | - | $14.02 M(+8.7%) |
| Dec 2021 | $50.23 M | $12.90 M(-12.2%) |
| Sep 2021 | - | $14.70 M(+25.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $11.73 M(+7.5%) |
| Mar 2021 | - | $10.90 M(-16.2%) |
| Dec 2020 | $39.56 M(-10.2%) | $13.01 M(+83.5%) |
| Sep 2020 | - | $7.09 M(-9.8%) |
| Jun 2020 | - | $7.85 M(-32.4%) |
| Mar 2020 | - | $11.61 M(+80.5%) |
| Dec 2019 | $44.08 M(+16.4%) | $6.44 M |
| Dec 2018 | $37.86 M | - |
FAQ
- What is Decibel Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Decibel Therapeutics?
- What is Decibel Therapeutics annual operating expenses year-on-year change?
- What is Decibel Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Decibel Therapeutics?
- What is Decibel Therapeutics quarterly operating expenses year-on-year change?
What is Decibel Therapeutics annual total operating expenses?
The current annual operating expenses of DBTX is $63.96 M
What is the all time high annual operating expenses for Decibel Therapeutics?
Decibel Therapeutics all-time high annual total operating expenses is $63.96 M
What is Decibel Therapeutics annual operating expenses year-on-year change?
Over the past year, DBTX annual total operating expenses has changed by +$13.73 M (+27.33%)
What is Decibel Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of DBTX is $19.04 M
What is the all time high quarterly operating expenses for Decibel Therapeutics?
Decibel Therapeutics all-time high quarterly total operating expenses is $19.04 M
What is Decibel Therapeutics quarterly operating expenses year-on-year change?
Over the past year, DBTX quarterly total operating expenses has changed by +$1.94 M (+11.33%)